Nexalin Technology Stock In The News

NXL Stock  USD 1.19  0.04  3.48%   
Our overall analysis of Nexalin Technology's news coverage and content from conventional and social sources shows investors' bearish mood towards Nexalin Technology. The specific impact of Nexalin Technology news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Nexalin Technology's overall financial health and prospects. It also depends on the type and quality of a news publisher. Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Nexalin Technology headlines in addition to utilizing other, more conventional financial analysis modules. Check out Nexalin Technology Backtesting and Nexalin Technology Hype Analysis.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.

Nexalin Technology Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David Lasseter
https://www.globenewswire.com/news-release/2023/10/25/2766524/0/en/Nexalin-Technology-Announces-Formation-of-New-Military-Government-Advisory-Board-to-be-Led-by-Government-Affairs-Veteran-David-Lasseter.html
 Bullish
Macroaxis News: globenewswire.com
Nexalin Technology Announces Publication...
https://www.globenewswire.com/news-release/2023/10/16/2760653/0/en/Nexalin-Technology-Announces-Publication-of-Groundbreaking-Deep-Brain-Stimulation-Study-in-Leading-Peer-Reviewed-Journal-Validates-the-Ability-of-Nexalin-s-Neurostimulation-Device-.html
 Bullish
Macroaxis News: globenewswire.com
Nexalin Technology Reports Results of Cl...
https://www.globenewswire.com/news-release/2023/08/07/2719691/0/en/Nexalin-Technology-Reports-Results-of-Clinical-Study-Supporting-the-Therapeutic-Benefits-of-its-Gen-2-15-Milliamp-Neurostimulation-Device-in-Treating-Migraine-Headaches-and-Related.html
 Neutral
Macroaxis News: globenewswire.com
Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time
https://www.globenewswire.com/news-release/2023/08/03/2718034/0/en/Nexalin-s-CEO-Mark-White-to-be-Interviewed-Live-on-The-Big-Biz-Show-Today-at-3PM-Eastern-Time.html
 Neutral
Macroaxis News: globenewswire.com
Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies
https://www.globenewswire.com/news-release/2023/07/26/2711306/0/en/Nexalin-Technology-Announces-New-Public-Sector-Division-to-Capitalize-on-Opportunities-to-Serve-U-S-Government-Agencies.html
 Bullish
Macroaxis News: globenewswire.com
Nexalin Technology Announces Abstract Ac...
https://www.globenewswire.com/news-release/2023/07/10/2701772/0/en/Nexalin-Technology-Announces-Abstract-Accepted-for-Presentation-at-2023-Military-Health-System-Research-Symposium-Validating-the-Potential-of-its-Non-Invasive-Frequency-Based-Deep-.html
 Neutral
Macroaxis News: globenewswire.com
Nexalin Technology, Inc. and Wider Come ...
https://www.globenewswire.com/news-release/2023/06/01/2680332/0/en/Nexalin-Technology-Inc-and-Wider-Come-Limited-Announce-Joint-Venture-Agreement-to-Advance-Commercialization-of-Nexalin-s-tACS-Devices-in-the-Asia-Pacific-Region.html
 Neutral
Macroaxis News: globenewswire.com
Nexalin Technology Provides 2022 Year-End Business Update
https://www.globenewswire.com/news-release/2023/03/27/2634607/0/en/Nexalin-Technology-Provides-2022-Year-End-Business-Update.html
 Bullish
Macroaxis News: globenewswire.com
Nexalin Technology Appoints Medical Device Veteran Michael Nketiah as Senior Vice President of Quality, Clinical and Regulatory
https://www.globenewswire.com/news-release/2023/01/24/2594202/0/en/Nexalin-Technology-Appoints-Medical-Device-Veteran-Michael-Nketiah-as-Senior-Vice-President-of-Quality-Clinical-and-Regulatory.html
 Bullish
Macroaxis News: globenewswire.com
Nexalin Technology CEO Provides Letter to Shareholders
https://www.globenewswire.com/news-release/2023/01/05/2583743/0/en/Nexalin-Technology-CEO-Provides-Letter-to-Shareholders.html
 Bullish

Nexalin Technology Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Nexalin and other traded companies coverage with news coverage. We help investors stay connected with Nexalin headlines for the 18th of June 2025 to make an informed investment decision based on correlating the impacts of news items on Nexalin Stock performance. Please note that trading solely based on the Nexalin Technology hype is not for everyone as timely availability and quick action are needed to avoid losses.
Nexalin Technology's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Nexalin Technology investors visualize upcoming and past events in order to time the market based on Nexalin Technology noise-free hype analysis.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nexalin Technology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nexalin Technology's short interest history, or implied volatility extrapolated from Nexalin Technology options trading.
When determining whether Nexalin Technology is a strong investment it is important to analyze Nexalin Technology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexalin Technology's future performance. For an informed investment choice regarding Nexalin Stock, refer to the following important reports:
Check out Nexalin Technology Backtesting and Nexalin Technology Hype Analysis.
For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.84)
Revenue Per Share
0.012
Quarterly Revenue Growth
(0.48)
Return On Assets
(1.89)
Return On Equity
(3.68)
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.